Last Updated: October 2, 2025
Analyzing Management
Leadership at public companies plays a pivotal role for hedge funds and asset managers during both initial due diligence and ongoing risk assessment. ManagementTrack offers a consistent framework that eliminates distractions by highlighting distinct strengths and weaknesses, identifying notable warning signs and advantages, and drawing a clear connection between CEO choices and financial performance.
CEO Coric’s funding skill won’t save pipeline from clinical/regulatory risk.
Analysis of Biohaven CEO Vladimir Coric: Negative
Despite elite skill in securing funding, a consistent pattern of late-stage clinical failures and regulatory setbacks leaves Vladimir Coric poorly positioned to successfully advance the company’s high-risk pipeline.
Management evaluated Vladimir Coric’s track record and skillset against the following key factors for BHVN:
- Advancing novel degrader platforms into pivotal trials.
- Executing high-risk pivot of taldefgrobep into obesity.
- Navigating complex FDA review for Vyglxia approval.
- Managing high cash burn to fund the pipeline.
Vladimir Coric’s Track Record & Key Open Questions to Research
ManagementTrack provides track record analysis, career playbooks, strengths, and weaknesses for every CEO. It allows investors to dig deeper to uncover hard to find data to answer the most pressing questions.
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ for more information.
Question #1
Given the pipeline’s history of clinical failures, does Coric possess the R&D discipline to kill unpromising programs early, or does his elite skill in fundraising and deal-making create a temptation to keep high-risk assets alive longer than the science justifies?
Question #2
When faced with ambiguous clinical data for a high-potential asset, does Coric prioritize maintaining the strategic narrative for investors, or does he enforce rigorous, data-driven discipline on his development team, even if it means abandoning a promising story?
Question #3
Was the extraordinary success of the Nurtec sale a repeatable playbook based on Coric’s scientific acumen in asset selection, or was it a singular triumph of financial engineering and commercial execution that will be difficult to replicate with the current, internally-focused pipeline?
Why Do Investors Use ManagementTrack?
Q: What is ManagementTrack’s analysis of Vladimir Coric at BHVN?
A: ManagementTrack determines Vladimir Coric’s track record, key strengths, and weaknesses by leveraging its proprietary career analysis and interviews with former colleagues. This profile is then evaluated against BHVN’s most critical challenges, such as advancing novel degrader platforms into pivotal trials, executing a high-risk pivot into obesity, navigating a complex FDA review for a key asset, and managing a high cash burn to fund the pipeline.
Q: What additional methods does ManagementTrack use to connect executive actions to future company performance?
A: ManagementTrack utilizes proprietary models to detect and analyze executive evasion in earnings call Q&A, determining if such behavior is anomalous. Its analysis also extends to all insider transactions, identifying outlier trades that are predictive of future stock performance. These factors are synthesized into the ManagementTrack Rating, a proprietary 1-10 predictive score for every executive, which gives investors a clear, directional view on how management will influence the company’s future.
Q: What is the scope of ManagementTrack’s coverage?
A: ManagementTrack provides real-time coverage of the C-suite for every publicly traded company.
How to Learn More
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ to see our deep dive analysis on any executive.
Author
Author Colby Howard is the co-founder and President of Paragon Intel. Paragon Intel’s ManagementTrack is the premier executive analysis platform for hedge funds, asset managers, corporations, boards, and recruiters. Our proprietary data, built over a decade of analysis, allows us to analyze each public company executive to understand their fit and ability to execute at their company. We leverage our proprietary data – key quantitative research on an executive’s career plus interviews with their former colleagues – with public documents, including SEC filings (10-K, 10-Q), investor presentations, press releases, and earnings call transcripts. to build a holistic, evidence-based view of an executive’s capabilities and playbook.
Sources
- Verified Career History by ManagementTrack for Vladimir Coric
- Analysis of Capital Allocation, Performance, and Fundamentals across career by ManagementTrack
- Biohaven Ltd. 10Q
- Biohaven Ltd. 10K
- Biohaven Ltd. Earnings Calls
- Biohaven Ltd. Press Releases
Relevant Links
- For more information on ManagementTrack’s Data visit: https://paragonintel.com/management-track-data/
- For more information on ManagementTrack’s Interview & Analysis visit: https://paragonintel.com/management-track-reports/
- For more information on ManagementTrack’s Interview library visit: https://paragonintel.com/management-track-report-library/
- For more information on ManagementTrack’s Evasion Analysis visit: https://paragonintel.com/earnings-call-evasion/
- For more information on how ManagementTrack helps hedge funds and asset managers visit: https://paragonintel.com/
